Deep Brain Stimulation for Movement Disorders
Trial Summary
What is the purpose of this trial?
Background: - In deep brain stimulation (DBS), a device called a neurostimulator is placed in the chest. It is attached to wires in parts of the brain that affect movement. DBS might help people with movement disorders like Parkinson s disease (PD), dystonia, and essential tremor (ET). Objective: - To provide DBS treatment to people with some movement disorders. Eligibility: - Adults 18 years and older with PD, ET, or certain forms of dystonia. Design: * Participants will be screened with medical history and physical exam. They will have blood and urine tests and: * MRI brain scan. The participant will lie on a table that slides in and out of a metal cylinder with a magnetic field. They will be in the scanner about 60 minutes. They will get earplugs for the loud noises. During part of the MRI, a needle will guide a thin plastic tube into an arm vein and a dye will be injected. * Electrocardiogram. Metal disks or sticky pads will be placed on the chest, arms, and legs. They record heart activity. * Chest X-ray. * Tests of memory, attention, concentration, thinking, and movement. * Eligible participants will have DBS surgery. The surgery and hospital care afterward are NOT part of this protocol. * Study doctors will see participants 3 4 weeks after surgery to turn on the neurostimulator. * Participants will return every month for 3 months, then every 3 months during the first year, and every 6 months during the second year. Each time, participants will be examined and answer questions. DBS placement will be evaluated with MRI. The neurostimulator will be programmed. At two visits, participants will have tests of movements, thinking, and memory.
Will I have to stop taking my current medications?
The trial protocol does not specify if you need to stop taking your current medications. However, it mentions that participants should have an unsatisfactory response to their current medical management, which might imply some changes could be necessary. It's best to discuss your specific medications with the study doctors.
What data supports the effectiveness of the treatment Deep Brain Stimulation for movement disorders?
Deep Brain Stimulation (DBS) is shown to be highly effective for treating movement disorders like essential tremor, Parkinson's disease, and dystonia. Studies indicate that DBS can reduce tremor severity by about 50% and improve motor symptoms and quality of life significantly in patients with these conditions.12345
Is Deep Brain Stimulation generally safe for humans?
How is Deep Brain Stimulation different from other treatments for movement disorders?
Deep Brain Stimulation (DBS) is unique because it uses electrical impulses to modulate specific brain regions in a reversible and adjustable way, unlike other treatments that may involve permanent changes or medications. It is particularly effective for advanced movement disorders like Parkinson's disease, essential tremor, and dystonia, offering an option when medications are no longer effective.23111213
Research Team
Debra J Ehrlich, M.D.
Principal Investigator
National Institute of Neurological Disorders and Stroke (NINDS)
Eligibility Criteria
This trial is for adults over 18 with Parkinson's Disease (PD), essential tremor (ET), or certain dystonias who've had a good response to dopaminergic meds for PD. It's not suitable for those with significant medical risks, secondary movement disorders, dementia, pregnancy, psychiatric issues, or an inability to undergo MRI scans.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Surgery and Initial Programming
Eligible participants will have DBS surgery. Study doctors will see participants 3-4 weeks after surgery to turn on the neurostimulator.
Follow-up
Participants will return every month for 3 months, then every 3 months during the first year, and every 6 months during the second year. Each time, participants will be examined and answer questions. DBS placement will be evaluated with MRI. The neurostimulator will be programmed.
Long-term Follow-up
Participants have the option to transfer their care back to the neurologists in the community or continue care with the NIH Neurology team until care in the community is available.
Treatment Details
Interventions
- Deep Brain Stimulation (Procedure)
- Deep Brain Stimulation Management (Procedure)
Deep Brain Stimulation is already approved in Canada for the following indications:
- Essential tremor
- Parkinson's disease
- Dystonia
- Obsessive-compulsive disorder
- Epilepsy
- Chronic pain
Find a Clinic Near You
Who Is Running the Clinical Trial?
National Institute of Neurological Disorders and Stroke (NINDS)
Lead Sponsor
Jordan Gladman
National Institute of Neurological Disorders and Stroke (NINDS)
Chief Medical Officer
MD from Harvard Medical School
Walter J. Koroshetz
National Institute of Neurological Disorders and Stroke (NINDS)
Chief Executive Officer since 2007
MD from the University of Chicago